Forwarded from 👊Wake up 👊 (J.Z)
This media is not supported in your browser
VIEW IN TELEGRAM
一种有益的肠道细菌 Akkermansia muciniphila 在增强癌症免疫疗法的有效性方面显示出良好的前景。
免疫检查点抑制剂是一种癌症免疫疗法，可帮助免疫系统攻击癌细胞，但它们仅对有限数量的患者有效，并且通常会带来严重的副作用。
最近的研究发现，肠道中阿克曼菌水平较高的患者对免疫疗法的反应往往更好。这可能是由于其具有支持免疫调节和减缓肿瘤生长的能力。
此外，阿克曼氏菌还具有减轻炎症、改善肠道屏障功能以及减轻癌症治疗副作用的潜力。
Akkermansia muciniphila, a beneficial gut bacterium, is showing promise in enhancing the effectiveness of cancer immunotherapy.
Immune checkpoint inhibitors, a type of cancer immunotherapy, help the immune system attack cancer cells, but they only work for a limited number of patients and often come with serious side effects.
Recent studies have found that patients with higher levels of Akkermansia in their gut tend to have better responses to immunotherapy. This may be due to its ability to support immune regulation and slow tumor growth.
Additionally, Akkermansia has been linked to reduced inflammation, improved gut barrier function, and the potential to lessen the side effects of cancer treatments.
免疫检查点抑制剂是一种癌症免疫疗法，可帮助免疫系统攻击癌细胞，但它们仅对有限数量的患者有效，并且通常会带来严重的副作用。
最近的研究发现，肠道中阿克曼菌水平较高的患者对免疫疗法的反应往往更好。这可能是由于其具有支持免疫调节和减缓肿瘤生长的能力。
此外，阿克曼氏菌还具有减轻炎症、改善肠道屏障功能以及减轻癌症治疗副作用的潜力。
Akkermansia muciniphila, a beneficial gut bacterium, is showing promise in enhancing the effectiveness of cancer immunotherapy.
Immune checkpoint inhibitors, a type of cancer immunotherapy, help the immune system attack cancer cells, but they only work for a limited number of patients and often come with serious side effects.
Recent studies have found that patients with higher levels of Akkermansia in their gut tend to have better responses to immunotherapy. This may be due to its ability to support immune regulation and slow tumor growth.
Additionally, Akkermansia has been linked to reduced inflammation, improved gut barrier function, and the potential to lessen the side effects of cancer treatments.